HAS2 and neoplasm: Therefore, changes in the relative expression or activation of HAS2 versus HAS3 could critically influence HA size distribution and in turn, modulate melanoma cell behaviour, including adhesion, motility, and interactions with the tumour microenvironment (Figure 6).